What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q1 2019?

64 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q1 2019. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / Common Stock
Total 13F shares: 14,726,528
Total 13F value: $209,555,043
Share change: +10,868,724
Put/Call ratio: 52%
SEC-reported price per share: $14.23
Number of holders: 64
Value change: +$159,660,613
Number of buys: 49
Number of sells: 18
Shares outstanding: 51,632,132

Security key

05464T104

Report period

Q1 2019

Institutions

Top holders

AXSM full security history Ownership snapshot Full 13F holder table Axsome Therapeutics, Inc. SEC filings Axsome Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ALETHEA CAPITAL MANAGEMEN...

Disclosed value leader

ALETHEA CAPITAL MANAGEMEN...

Comparable rows

15/15

Latest evidence

31 Dec 2018

13F Lead comparable stake: 1.8% Showing 1-6 of 15 holder rows.

Quick read

ALETHEA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 1.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ALETHEA CAPITAL MANAGEMENT, LLC's linked filing trail.

Comparable ownership Top 5

ALETHEA CAPITAL MANAGEMENT, LLC 1.8%

STIFEL FINANCIAL CORP 0.78%

Sio Capital Management, LLC 0.74%

VANGUARD GROUP INC 0.66%

ROYCE & ASSOCIATES LP 0.64%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ALETHEA CAPITAL MANAGEMENT, LLC	13F Company 13F	1.8%	$2,562,000 908,429 shares	—	31 Dec 2018
STIFEL FINANCIAL CORP	13F Company 13F	0.78%	$1,140,000 404,145 shares	—	31 Dec 2018
Sio Capital Management, LLC	13F Company 13F	0.74%	$1,074,000 380,812 shares	—	31 Dec 2018
VANGUARD GROUP INC	13F Company 13F	0.66%	$955,000 338,704 shares	—	31 Dec 2018
ROYCE & ASSOCIATES LP	13F Company 13F	0.64%	$937,000 332,400 shares	—	31 Dec 2018
MILLENNIUM MANAGEMENT LLC	13F Company 13F	0.6%	$871,000 308,802 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

14,726,528

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %